Generics and Biosimilars in Central and Eastern Europe
June 25 - 26, 2013 - Warsaw PLInterContinental Warsaw
hello@evvnt.com
Phone:215-418-4700
Fax:215-418-4700
Summary: Focusing on opportunities and challenges, senior directors, partners and board members will discuss trends in generic and biosimilar development, manufacturing and commercialisation. Description: Attend to benefit from: A detailed overview of the generics and biosimilars landscape in CEE, including a macro-economic outlook on the region: Pinpoint key trends in the hottest markets – Poland, Slovakia and Ukraine. - Useful insights into the complex legal and regulatory framework: Ensure your company is fully prepared to tackle upcoming changes. - Learning about various partnering strategies, their benefits and ground-breaking examples of effective International co-operation. - An excellent opportunity for international companies to learn how to access the market in CEE and be commercially successful. - A review of differentiation strategies for generics, focusing on super generics. Tuesday June 25, 2013 at 9:00 am, ends Wednesday June 26, 2013 at 3:30 pm. URLs: Booking: http://atnd.it/10gRJ7G Price: €1413.27 Keywords: biosimilars, generics, europe. Artists / Speakers: Vladimir Zah, Nicola Travierso, Agnieszka Skonieczna, Natalia Salamova, Federico Pollano, Iris Margraf, Alex Kudrin, Oleksandr Kryuk, Ranjith Gopinathan, Milosz Gruca, Klaus Martin, Rok Hren, Vojtěch Mészáros, Alan Sheppard.